Navigation Links
Stage Set For Final Hearing On India’s Biggest Ever Medical Compensation Clai

The stage is set for the final hearing of India's biggest ever medical compensation claim against doctors of a Kolkata hospital charged with negligence in a woman's death eight years ago.//

"I am hopeful about tomorrow, though I realise my case can again be postponed by the machinations of my opponents," Ohio-based AIDS researcher Kunal Saha told IANS Wednesday, a day ahead of the final hearing at the National Consumer Disputes Redressal Commission (NCDRC).

"If necessary, I will move the Supreme Court and see the end of this case," he added.

Saha had filed a Rs.770 million ($17 million) claim against a Kolkata hospital after the death of his wife Anuradha Saha, 36, due to alleged wrong treatment by three senior doctors in May 1998 when the couple were on a visit to India.

In the process, he has scripted one of the most high profile medical negligence cases in India.

"The claim will be over Rs.1 billion now because of the interest for the past eight years, but I have already given in writing that I would not take back a single penny to the US. The entire compensation money would be donated for healthcare in India," he said.

"Because of repeated judicial bottlenecks, I am forced to bear heavy expenses on my travels between India and US," said Saha.

"Only about three months back I had to be in India for the case, but it did not happen. Now also if it is not adjudicated, I will move the apex court," he said.

Video-conferencing has been extensively used in testimonies and cross-examinations in the case.

Saha had filed case against three doctors - Baidyanath Halder, Abani Roychowdhury and Sukumar Mukherjee - besides the AMRI hospital in Kolkata where Anuradha, a child psychologist, was treated.

She was later shifted to the Breach Candy Hospital in Mumbai where she died from the TEN (Toxic Epidermal Necrolysis) syndrome, a life-threatening ski
'"/>




Page: 1 2

Related medicine news :

1. Detecting Lung Cancer In Its Initial Stages
2. New Oral Medication That Could Arrest Autoimmune Diseases In its early Stages
3. New Screening Method Found To Detect Testicular Cancer In Its Initial Stages
4. Herceptin for Early Stage Breast cancer
5. Senile Dementia Can Be Detected In Its Early Stages
6. Lung Cancer Goes Undetected In The Early Stages
7. Nursing A Threat : NHS Nurses May Stage A Royal Protest
8. HIV Vaccine Field Trials In Advanced Stage
9. Motherhood At Later Stage Could Lead To Heart Attacks
10. Cancer Therapy from Early Stage
11. European Medicines Agency (EMEA) Recommends Herceptin For Early Stage Breast Cancer
Post Your Comments:
(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...zart, could have a therapeutic effect on epilepsy,...448 have been found to decrease epileptic attacks....national research on music therapy, said it was ve...ns could also trigger the "Mozart Effect." Patient...
...at Kansas State University have published the firs...educed by another compound in the egg, the lecith...Jiang and Sang K. Noh. A peer-reviewed research pa...choline decreses the lymphatic absorption of chole...
...(MSI), the sole franchisee for US based Medicine S...vi Mumbai, Baroda and Pune, has dropped Chennai fr...y. According to informed sources, MSI, which recen...ions from the present 19 outlets to 50 by the end ...
... levels may depend not only on what he or she eats...iddle-aged and older adults who ate frequently thr...vels compared with those who tended to down one or...act that the frequent eaters, on average, had a hi...
Other Medicine News:Health News:Lecithin lowers cholesterol absorption in body 2
(Date:9/3/2008)...alysis showed that Multaq(R) (dronedarone) decreas...l fibrillation or atrial flutter already ... BRIDGEWATER, N.J., Sept. 3 /PRNewswire-FirstCall/... from the ATHENA study were presented today at,the...iety of Cardiology,congress 2008, in Munich, Germa...
(Date:9/3/2008)...09 to be Evaluated in Repeat-Dosing Study in Subje...re-FirstCall/ -- Sangamo,BioSciences, Inc. (Nasdaq...se,2 clinical trial (SB-509-801) to evaluate its d...degenerative motor-neuron disease for which there,...mo,s drug, SB-509, is an injectable formulation of...
(Date:9/2/2008)...elegates Join World Vision, ONE to Build Hope and ...swire/ -- Delegates to the,Republican Party Conven...communities around the world including evacuees in...V and AIDS in developing countries: "We are here,t...nviting party delegates to do,something unconventi...
(Date:9/2/2008)...t of three ongoing randomized chemotherapy combina...atment of specific cancers -, ROCKVILLE, Md., Sep...es, Inc. (Nasdaq: HGSI ) today reported initial t...clinical trial of its TRAIL receptor antibody,HGS-...(Velcade) in patients,with advanced multiple myelo...
Breaking Medicine Technology:Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 2Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 3Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 4Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 2Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 3Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 4Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 5Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 6AWWA Urges Science Based Approach in Addressing Pharmaceutical Compounds in Water 16924 1AWWA Urges Science Based Approach in Addressing Pharmaceutical Compounds in Water 16924 2AWWA Urges Science Based Approach in Addressing Pharmaceutical Compounds in Water 16924 3Antioxidant users dont live longer analysis of studies concludes 2904 1Antioxidant users dont live longer analysis of studies concludes 2904 2Antioxidant users dont live longer analysis of studies concludes 2904 3Hereditary breast cancer a high cost to patient and health care provider alike 16918 1Hereditary breast cancer a high cost to patient and health care provider alike 16918 2Hereditary breast cancer a high cost to patient and health care provider alike 16918 3Senetek PLC Reports 2007 Financial Results 16915 1Senetek PLC Reports 2007 Financial Results 16915 2Senetek PLC Reports 2007 Financial Results 16915 3
...07. Giaconda Ltd (ASX: GIA) today,announced that t...ved the Company,s Investigational New Drug applica...aR to treat patients with,Crohn,s Disease infected...P). , ,The Company understands that its lead produ...d to the FDA for this indication. There,are no ant...
..., 2007 /PRNewswire-FirstCall/ --,Allos Therapeutic...,European Communities, with a favorable opinion of...e European Medicines Agency (EMEA),has granted or...olate PDX (pralatrexate) for the treatment of pati...ly 2006, the U.S. Food and,Drug Administration (FD...
Other Medicine Technology:FDA approves MyocondaR IND for MAP in Crohn's Disease 2FDA approves MyocondaR IND for MAP in Crohn's Disease 3FDA approves MyocondaR IND for MAP in Crohn's Disease 4Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 2Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 3Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 4
...iCharts, is a state-of-the-art electronic medical ...8. It is a proven, comprehensive electronic medica...are providers at the point of care and to be share...nternet. AmkaiCharts chronicles patient history, e...
...fice seamlessly integrates practice management and...nd clinical workflow. Instantly access registratio...eporting information for multiple practices, provi...tely improves productivity by simplifying office w...
The ReSeeVit Slit Lamp System is an easy-to-use digital video imaging system that captures anterior segment and retinal images for documentation, diagnosis and patient education. The package includes
...e is an important movement in our country to provi...ns. In fact, recent government regulations require...s device affords your wheelchair-bound patients ea...t without having to leave their wheelchair. , ,The...
Medicine Products: